MedPath

Furosemide

FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg

Approved
Approval ID

33ec71e2-8fbd-0703-e063-6294a90a62e1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 29, 2025

Manufacturers
FDA

Coupler LLC

DUNS: 119003108

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Furosemide

PRODUCT DETAILS

NDC Product Code67046-1555
Application NumberANDA077293
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateApril 29, 2025
Generic NameFurosemide

INGREDIENTS (7)

FUROSEMIDEActive
Quantity: 80 mg in 1 1
Code: 7LXU5N7ZO5
Classification: ACTIB
STARCH, PREGELATINIZED CORNInactive
Code: O8232NY3SJ
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Furosemide - FDA Drug Approval Details